Column: Keep your price controls off weight-loss drugs
On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs for weight loss. It's unclear what the Trump administration will do with its predecessor's proposal. Democrats may be …